China is world No 2 economy, therefore there are many China business related stocks in the world (Singapore, China, Hong Kong, Taiwan, US). The quality of China related stocks could vary significantly, including 111 S-Chip stocks in Singapore with 20% weak stocks are suspended and also some strong China stocks could double the share price in a short period. In this article, you will learn from Dr Tee on 4 China related Giant Stocks which are efficient in making money with strong business growth in Greater China market (China, Hong Kong, Taiwan). Bonus for readers who could read every words of the entire article, learning unique strategy for each giant stock. 1) Singapore All-Rounded Giant Stock (S-Chip / A-Share) – Tianjin Zhongxin Pharmaceutical Group (SGX: T14 / China

Between life and money, which is more important? In this article, you will learn from Dr Tee on 11 Singapore Healthcare Giant Stocks which are efficient in making money with life as an economic moat, while some surge in prices during COVID-19 stock crisis. 1) COVID-19 “Crisis as Opportunity” Stocks Medtecs International Corporation (SGX: 546) UG Healthcare Corporation (SGX: 41A) Top Glove Corporation (SGX: BVA) Riverstone Holdings (SGX: AP4) 2) Medical Services Stocks Q&M Dental Group (SGX: QC7) Raffles Medical Group (SGX: BSL) 3) Healthcare Products Stocks Tianjin Zhong Xin Pharmaceutical Group (SGX: T14) Haw Par Corporation (SGX: H02) 4) Healthcare REITs First Reit (SGX: AW9U) ParkwayLife Reit (SGX: C2PU) IHH Healthcare (SGX: Q0F)

By Mak Yuen Teen On July 5, I posted an article “Biolidics’ Disclosures Are Simply Unacceptable” in which I questioned why Biolidics did not timely disclose the fact that its exclusive distribution agreement with Nasdaq-listed Aytu Bioscience (Aytu) was not progressing according to its original announcement on April 23. In the announcement on April 23, it was said that Aytu has a binding... Source

The STI lost 34 points or 1.4% at 2,618.48; Bad economic news depressed prices, vaccine hopes and firm Wall St provided support; Local economy contracted a record 12.6% in 2Q, entered into a technical recession; SGX queried Biolidics over disclosure of its A*Star agreement; Resorts World retrenched staff; Top Glove and other healthcare firms were in play Vaccine hopes vs weak economic news The main feature of last week’s trading was that even as the economic news continued to worsen, stocks remained supported. The source of the support was twofold – the extraordinary monetary injections by central banks and hopes that a vaccine for the COVID-19 virus might be found sooner rather than later. The main inspiration for buying stocks came from Wall Street, where investors appeared ready

Updated on July 18, 2020 to correct the following statement: “c. Why did the company agree to give a full refund, including for the 13,000 test kits that had been delivered, given that Aytu had a binding commitment to buy 500,000 test kits? Why is that in the interest of the company?” The refund is for the deposits paid for undelivered kits. The company is not required to give a refund for the 13... Source

By Mak Yuen Teen On July 14, 10.46 pm, Biolidics announced a five-year non-exclusive licensing agreement with Accelerate Technologies Pte Ltd (A*ccelerate), the commercialisation arm of A*STAR. The announcement said that the agreement was signed on Thursday, July 9. On Monday, July 13, 12.19 pm, a trading halt was called. Prior to the trading halt, the company’s share price had increased from 41... Source

By Mak Yuen Teen On April 26, I published an article called “Battling Disclosure Viruses” on this website where I discussed the placement of shares by Biolidics in March and its disclosures between March and April about its COVID-19 rapid antibody test kits. Coincidentally, later that same evening, the company published its responses to another set of SGX queries and its answers to questions posed... Source

Healthcare stocks (eg. hospital business, pharmaceutical companies, vaccine development, etc.) are having competitive advantages, therefore those with growing businesses are usually growth giant stocks. Between life and money, which is more important? The choice is clear (金钱诚可贵、生命价更高) to put life at a higher priority, therefore healthcare has been a high growth sector in most countries. Q&M Dental (SGX: QC7) is a young healthcare giant stock with focus in dental services. The company started business in year 1996, having main businesses in Singapore (79 branches), Malaysia and China.  For China, due to stronger competition and higher cost, subsidiary stock, Aoxin Q&M (SGX: 1D4) with poorer business there, is not a giant stock, not performing as go

By Mak Yuen Teen Starting from the end of March 2020, Catalist-listed Biolidics Limited made a series of announcements and press releases, and received extensive coverage in the local and international television and print media, regarding its “rapid test kits” for COVID-19. Its price and trading volume went off the charts. On the day of the first announcement and press release on 30 March at 5. Source